Scleroderma lung disease: evolving understanding in light of newer studies.

  title={Scleroderma lung disease: evolving understanding in light of newer studies.},
  author={K. M. Antoniou and Athol U Wells},
  journal={Current opinion in rheumatology},
  volume={20 6},
PURPOSE OF REVIEW To review therapeutic goals in pulmonary fibrosis in systemic sclerosis in the light of pathogenetic thinking and therapeutic data, with particular attention to recent data questioning the importance of the identification of alveolitis. RECENT FINDINGS Immunological/inflammatory activation remains the primary therapeutic target, based on recent data. Other effective therapies have not been developed, despite investigation of many pathogenetic pathways. In most cases, lung… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-9 of 9 citations


Publications referenced by this paper.
Showing 1-10 of 41 references